Log In
BCIQ
Print this Print this
 

DS107G, oral DS107 (Oral DGLA)

  Manage Alerts
Collapse Summary General Information
Company DS Biopharma
DescriptionOral formulation of 15-hydroxyeicosatrienoic acid
Molecular Target Not applicable
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis; Treat moderate to severe atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today